Hybrid risk adjustment for pharmaceutical benefits

Welcome to the UPF Digital Repository

García-Goñi, Manuel; Ibern, Pere; Inoriza, José María. Hybrid risk adjustment for pharmaceutical benefits. 2009
http://hdl.handle.net/10230/4592
To cite or link this document: http://hdl.handle.net/10230/4592
dc.contributor.author García-Goñi, Manuel
dc.contributor.author Ibern, Pere
dc.contributor.author Inoriza, José María
dc.contributor.other Universitat Pompeu Fabra. Departament d'Economia i Empresa
dc.date.issued 2009-01-01
dc.identifier.uri http://hdl.handle.net/10230/4592
dc.language.iso eng
dc.relation.ispartofseries Economics and Business Working Papers Series; 1139
dc.rights L'accés als continguts d'aquest document queda condicionat a l'acceptació de les condicions d'ús establertes per la següent llicència Creative Commons
dc.rights.uri http://creativecommons.org/licenses/by-nc-nd/3.0/es/
dc.title Hybrid risk adjustment for pharmaceutical benefits
dc.type info:eu-repo/semantics/workingPaper
dc.date.modified 2016-09-29T02:50:34Z
dc.subject.keyword Labour, Public, Development and Health Economics
dc.subject.keyword drug expenditure
dc.subject.keyword hybrid risk-adjustment
dc.subject.keyword morbidity
dc.subject.keyword clinical risk groups
dc.rights.accessRights info:eu-repo/semantics/openAccess


See full text
This document is licensed under a Creative Commons license:

Search


Advanced Search

Browse

My Account

Statistics